Come up with a name for your new list and we'll add to it:
Galera Therapeutics raised a round of funding on March 24, 2010. Investors include
St. Louis Arch Angels.
Galera Therapeutics is a clinical-stage biotechnology company, headquartered in Malvern, PA, focused on the development of breakthrough drugs targeting oxygen metabolic pathways. The Company's lead co…